|
|
Volumn 319, Issue 5865, 2008, Pages 884-885
|
|
Clinical research: Deaths in diabetes trial challenge a long-held theory
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
GLUCOSE;
HEMOGLOBIN A1C;
CLINICAL RESEARCH;
DIABETES CONTROL;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
MORTALITY;
NOTE;
PRIORITY JOURNAL;
STROKE;
THEORY;
TREATMENT OUTCOME;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
CONTROLLED CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
TIME FACTORS;
|
|
EID: 39349086991
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.319.5865.884 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|